Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Genmab A (GMAB) Net Margin (2024 - 2025)

Historic Net Margin for Genmab A (GMAB) over the last 2 years, with Q4 2025 value amounting to 108.6%.

  • Genmab A's Net Margin fell 1646100.0% to 108.6% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.0%, marking a year-over-year decrease of 424900.0%. This contributed to the annual value of 6.48% for FY2025, which is 427800.0% down from last year.
  • Per Genmab A's latest filing, its Net Margin stood at 108.6% for Q4 2025, which was down 1646100.0% from 47.16% recorded in Q3 2025.
  • Genmab A's 5-year Net Margin high stood at 56.01% for Q4 2024, and its period low was 108.6% during Q4 2025.